Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-10-19FDA Approved: AZULFIDINE EN-TABS — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Azulfidine EN-Tabs (sulfasalazine) from Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2009-10-16FDA Approved: RITUXAN — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Rituxan (rituximab) from Genentech.
-
CLINICAL_TRIALS trial_result · 2009-10-14Clinical Trial Update: A Study in Normal Healthy People, Testing Different Versions of a Pill That Will be Used to Treat Rheumatoid Arthritis. [Phase 1]
Pfizer completed a Phase 1 study in healthy volunteers to test multiple versions of an oral drug candidate intended to treat rheumatoid arth…
-
FDA approval · 2009-10-08FDA Approved: NEORAL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for NEORAL (cyclosporine) from Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2009-10-05Clinical Trial Update: Rheumatoid Arthritis Disease Activity Monitor
An update on a completed clinical trial evaluating a rheumatoid arthritis disease activity monitoring tool.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-10-01FDA Approved: SULINDAC — Supplemental Application (PuraCap Laboratories LLC dba Blu Pharmaceuticals)
FDA approved a supplemental application for the generic NSAID sulindac from PuraCap Laboratories LLC dba Blu Pharmaceuticals (ANDA072711).
-
FDA approval · 2009-09-24FDA Approved: MELOXICAM — Supplemental Application (Carlsbad Technology, Inc.)
The FDA approved a supplemental application for Meloxicam from Carlsbad Technology, Inc., indicating the supplemental action for the generic…
-
FDA approval · 2009-09-24FDA Approved: NEORAL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for NEORAL (cyclosporine) from Novartis Pharmaceuticals Corporation, authorizing changes to the …
-
CLINICAL_TRIALS trial_result · 2009-09-10Clinical Trial Update: Study Evaluating TMI-005 in Active Rheumatoid Arthritis [Phase 2]
Phase 2 study evaluating TMI-005 in active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-10Clinical Trial Update: Targeting Synovitis in Early Rheumatoid Arthritis [Phase 4]
A Phase 4 clinical trial update from NHS Greater Glasgow and Clyde investigates targeting synovitis in early rheumatoid arthritis. The curre…
-
CLINICAL_TRIALS trial_result · 2009-09-03Clinical Trial Update: A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis [Phase 1, Phase 2]
This clinical trial evaluated the safety of escalating doses of ocrelizumab in adults with rheumatoid arthritis in Phase 1 and Phase 2. The …
-
CLINICAL_TRIALS research · 2009-08-26Clinical Trial Update: Sensitivity of Echography in Arthritis [NA]
This clinical trial update reports an ongoing study assessing how sensitive ultrasound is for detecting arthritis in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis [Phase 1, Phase 2]
A Phase 1/2 trial comparing subcutaneous and intravenous ACZ885 (canakinumab) in adults with established rheumatoid arthritis was conducted,…
-
CLINICAL_TRIALS trial_result · 2009-08-21Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 When Added to Methotrexate [Phase 2]
A Phase 2 trial evaluating the addition of Rob 803 to methotrexate for rheumatoid arthritis has completed. Sponsor: OxyPharma.
-
CLINICAL_TRIALS trial_result · 2009-08-21Clinical Trial Update: A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417)
A completed feasibility study evaluating the effect of Remicade (infliximab) on disease activity in patients with rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2009-08-18Clinical Trial Update: Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis [Phase 4]
This Phase 4 trial update compares the effectiveness and safety of adalimumab versus infliximab in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2009-07-29Clinical Trial Update: Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects [Phase 1, Phase 2]
This update reports the completion of Phase 1 and Phase 2 trials evaluating intra-articular delivery of tgAAC94 for inflammatory arthritis, …
-
CLINICAL_TRIALS trial_result · 2009-07-23Clinical Trial Update: Pharmacogenetics of Antifolate Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis in Taiwan
A completed clinical trial investigating pharmacogenetic factors affecting response to antifolate disease-modifying antirheumatic drugs in r…
-
CLINICAL_TRIALS research · 2009-07-23Clinical Trial Update: Pharmacogenetics of Antifolate Drugs in Autoimmune Diseases in Taiwan
This clinical trial update discusses pharmacogenetic research on antifolate drugs used in rheumatoid arthritis in Taiwan, examining how gene…
-
CLINICAL_TRIALS trial_result · 2009-07-21Clinical Trial Update: A Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methorexate (Extension Part)(Study P05645)(COMPLETED) [Phase 3]
Phase 3 extension study of the anti-TNF chimeric monoclonal antibody cA2 in Korean patients with active rheumatoid arthritis despite methotr…
-
CLINICAL_TRIALS trial_result · 2009-07-16Clinical Trial Update: A Study to Investigate the Potential for AZD5672 to Affect the Electrical Conduction Pathways in the Heart [Phase 1]
Phase 1 study of AZD5672 by AstraZeneca for rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2009-07-14Clinical Trial Update: Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid Arthritis [Phase 1]
A Phase 1 dose-escalation study evaluated PD-0360324 in combination with methotrexate in patients with rheumatoid arthritis; the study has c…
-
CLINICAL_TRIALS trial_result · 2009-07-13Clinical Trial Update: A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive [Phase 3]
A Phase 3 study assessing the safety and efficacy of golimumab in methotrexate-naive rheumatoid arthritis patients; the trial completed with…
-
CLINICAL_TRIALS trial_result · 2009-07-07Clinical Trial Update: Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED) [Phase 2]
Phase 2 dose-ranging trial for rheumatoid arthritis completed; results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-07-07Clinical Trial Update: Maxim® Knee Pop-Top® Tibia vs. Regular Maxim® Knee Tibia [NA]
This clinical trial compared Maxim Knee Pop-Top Tibia to Regular Maxim Knee Tibia in patients with osteoarthritis, rheumatoid arthritis, or …